[Congressional Record Volume 170, Number 114 (Wednesday, July 10, 2024)]
[Senate]
[Pages S4525-S4526]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 2244. Mrs. SHAHEEN (for herself and Ms. Collins) submitted an 
amendment intended to be proposed by her to the bill S. 4638, to 
authorize appropriations for fiscal year 2025 for military activities 
of the Department of Defense, for military construction, and for 
defense activities of the Department of Energy, to prescribe military 
personnel strengths for such fiscal year, and for other purposes; which 
was ordered to lie on the table; as follows:

       At the end of subtitle H of title X, insert the following:

     SEC. 1095. PFAS HEALTH EFFECTS ASSESSMENT, RECOMMENDATIONS, 
                   AND GUIDANCE.

       (a) Periodic Assessment and Recommendations.--
       (1) Agreement.--The Director of the Agency for Toxic 
     Substances and Disease Registry (in this section referred to 
     as the ``Director'') shall enter into an agreement with the 
     National Academies of Sciences, Engineering, and Medicine (or 
     another appropriate entity if the National Academies declines 
     to enter into such agreement) under which the National 
     Academies or the other appropriate entity agrees--
       (A) to assess the health effects of per- and 
     polyfluoroalkyl substances (in this section referred to as 
     ``PFAS'') that can be measured in human tissues;

[[Page S4526]]

       (B) to formulate clinical recommendations on addressing 
     such health effects;
       (C) not later than 2 years after the date of entry into 
     such agreement, to complete the initial assessment under 
     subparagraph (A) and formulate the initial recommendations 
     under subparagraph (B); and
       (D) to update the most recent assessment and 
     recommendations under this paragraph--
       (i) every 5 years; or
       (ii) more frequently as determined necessary by the 
     Director based on an assessment of the science.
       (2) Consultation.--In carrying out the assessments under 
     paragraph (1), the National Academies of Sciences, 
     Engineering, and Medicine or other appropriate entity shall 
     engage with PFAS exposed communities and solicit input from 
     members of such communities regarding their experiences with 
     PFAS exposure, testing, and clinical follow-up.
       (3) Timing of entry into agreement.--The Director shall 
     enter into the agreement required by paragraph (1) not later 
     than 60 days after the date of enactment of this Act.
       (b) Up-to-Date Guidance.--Based on the results of the most 
     recent assessment and recommendations under subsection (a), 
     the Director, in consultation with the entity with which the 
     Director enters into the agreement under subsection (a), 
     shall--
       (1) not later than 5 years after the date of entry into the 
     agreement required by subsection (a)--
       (A) issue up-to-date clinical guidance on addressing the 
     health effects of PFAS;
       (B) post such guidance on the public website of the Agency 
     for Toxic Substances and Disease Registry; and
       (C) disseminate such guidance to State and local public 
     health authorities and appropriate health care professionals; 
     and
       (2) every 5 years thereafter, or more frequently as 
     determined necessary by the Director based on an assessment 
     of the science, issue, post, and disseminate up-to-date 
     guidance as described in paragraph (1).
                                 ______